Stock Research: Sartorius Stedim

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Sartorius Stedim

ENXTPA:DIM FR0013154002
33
  • Value
    16
  • Growth
    77
  • Safety
    Safety
    19
  • Combined
    12
  • Sentiment
    61
  • 360° View
    360° View
    33
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Sartorius Stedim Biotech SA provides laboratory and process technologies and equipment. It operates in the biotech, pharma, and food industries, with production facilities in Europe, Asia, and America and sales offices in over 110 countries. In the last fiscal year, the company had a market cap of $22,127 million, profits of $1,250 million, revenue of $2,878 million, and 9901 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 33 (better than 33% compared with alternatives), overall professional sentiment and financial characteristics for the stock Sartorius Stedim are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Sartorius Stedim. The consolidated Growth Rank has a good rank of 77, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 77% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 61, which means that professional investors are more optimistic about the stock than for 61% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 19, which means that the share price of Sartorius Stedim is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 81% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 16, which means that the company has a financing structure that is riskier than those of 84% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
CAC All
SBF 120
Diversity Europe
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 16-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
19 12 7 15
Growth
77 84 3 59
Safety
Safety
16 7 46 62
Sentiment
61 44 23 14
360° View
360° View
33 12 1 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
76 45 39 60
Opinions Change
50 75 28 12
Pro Holdings
n/a 39 20 57
Market Pulse
55 47 60 20
Sentiment
61 44 23 14
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
19 12 7 15
Growth
77 84 3 59
Safety Safety
16 7 46 62
Combined
12 9 1 34
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
18 14 12 28
Price vs. Earnings (P/E)
13 9 12 7
Price vs. Book (P/B)
28 19 14 8
Dividend Yield
34 29 28 28
Value
19 12 7 15
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
55 65 60 73
Profit Growth
83 81 6 76
Capital Growth
64 91 15 14
Stock Returns
47 30 21 55
Growth
77 84 3 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
22 19 44 54
Refinancing
31 22 19 19
Liquidity
15 31 83 88
Safety Safety
16 7 46 62

Similar Stocks

Discover high‑ranked alternatives to Sartorius Stedim and broaden your portfolio horizons.

Synergie

ENXTPA:SDG
Country: France
Industry: HR- & Employment Services
Size: Medium
Full Stock Analysis

Rubis

ENXTPA:RUI
Country: France
Industry: Gas Utilities
Size: Medium
Full Stock Analysis

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

BUSE:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Perrigo

NYSE:PRGO
Country: Ireland
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.